Streetbeat News

Stock Prices

CWD

CaliberCos (NASDAQ:CWD) shares surged 57.89% on their first day of trading after the company's IPO, closing at $6.00. CaliberCos offered 1.20 million shares at $4.00 per share, with an insider lock-up period of 180 days.

Portfolio Pulse from Benzinga Insights

May 18, 2023 | 9:30 pm

ACB

CARA

CRON

XXII

Cannabis stocks experienced significant gains and losses on May 18, 2023. Major gainers include 22nd Century Group, Cann Gr, Curaleaf Holdings, iAnthus Capital Hldgs, Aurora Cannabis, Cronos Group, MariMed, OrganiGram Holdings, and 4Front Ventures. Losers include Eastside Distilling, Cara Therapeutics, Emeren Group, Village Farms Intl, and Corbus Pharmaceuticals.

Portfolio Pulse from Benzinga Insights

May 18, 2023 | 9:30 pm

AMAT

Applied Materials (AMAT) reported Q2 earnings of $2.00 per share, beating the $1.84 estimate, and revenues of $6.63 billion, surpassing the $6.38 billion estimate. The company expects to outperform its peers in the semiconductor market in 2023.

Portfolio Pulse from AJ Fabino

May 18, 2023 | 9:16 pm

ELDN

Eledon Pharmaceuticals Inc has filed for an offering of 75.8 million shares of common stock to be offered by selling stockholders, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 9:13 pm

FTCH

Farfetch (NYSE:FTCH) reported better-than-expected Q1 results, with revenues of $556.4 million, an 8% YoY increase, and an EPS loss of $0.16, smaller than the expected $0.42 loss. The company expects FY23 Group GMV of approximately $4.9 billion.

Portfolio Pulse from Bill Haddad

May 18, 2023 | 9:11 pm

ARTNA

Artesian Resources plans to offer 600,000 shares of Class A non-voting common stock in an underwritten public offering. The proceeds will be used for general corporate purposes, including capital investment and repayment of outstanding debt.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 9:09 pm

DAWN

In the last quarter, Day One Biopharmaceutical (NASDAQ:DAWN) received 6 bullish and 1 somewhat bearish analyst ratings. The company's average 12-month price target is $39.29, down 6.45% from the previous average of $42.00.

Portfolio Pulse from Benzinga Insights

May 18, 2023 | 9:02 pm

ARRY

13 analysts have provided ratings for Array Technologies (NASDAQ:ARRY) in the last quarter, with an average price target of $25.85, implying an upside from the current price of $22.96. The average price target has increased by 1.37% over the past month.

Portfolio Pulse from Benzinga Insights

May 18, 2023 | 9:01 pm

DK

In the last quarter, Delek US Holdings (NYSE:DK) received 2 somewhat bullish, 4 indifferent, and 4 somewhat bearish analyst ratings. The average 12-month price target is $26.4, representing a 9.34% decrease from the previous average of $29.12.

Portfolio Pulse from Benzinga Insights

May 18, 2023 | 9:01 pm

INVZ

Innoviz Technologies (NASDAQ:INVZ) has received 2 bullish, 1 somewhat bullish, and 2 indifferent analyst ratings in the last quarter. The average 12-month price target for the stock is $5.2, down 25.71% from the previous average of $7.00.

Portfolio Pulse from Benzinga Insights

May 18, 2023 | 9:00 pm